Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -71,868 | -53,945 | -24,815 | -56,796 | -51,893 |
| Depreciation Amortization | 2,372 | 1,581 | 791 | 3,180 | 2,390 |
| Accounts payable and accrued liabilities | 5,535 | 6,466 | 209 | -2,056 | -3,329 |
| Other Working Capital | 10,077 | 11,215 | 1,744 | -3,782 | -1,648 |
| Other Operating Activity | 10,082 | 7,507 | 8,740 | 9,315 | 17,190 |
| Operating Cash Flow | $-43,802 | $-27,176 | $-13,331 | $-50,139 | $-37,290 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 5,057 | N/A | N/A | 43,211 | 42,481 |
| Other Financing Activity | -802 | 1,857 | 583 | 15,840 | 16,154 |
| Financing Cash Flow | $19,255 | $1,857 | $583 | $59,051 | $58,635 |
| Exchange Rate Effect | 104 | 72 | 15 | -309 | -365 |
| Beginning Cash Position | 142,142 | 142,142 | 142,142 | 133,539 | 133,539 |
| End Cash Position | 117,699 | 116,895 | 129,409 | 142,142 | 154,519 |
| Net Cash Flow | $-24,443 | $-25,247 | $-12,733 | $8,603 | $20,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,802 | -27,176 | -13,331 | -50,139 | -37,290 |
| Free Cash Flow | -43,802 | -27,176 | -13,331 | -50,139 | -37,290 |